Mark Michalski

Mark Michalski has a diverse work experience, starting from their role as a Medical Intern at St. Mary's Medical Center, San Francisco in 2010 to becoming the Chief Executive Officer at Ascertain in 2023. In between, they held various positions such as Faculty at Harvard Medical School, Executive Director at Mass General Brigham Data Science Office, and Principal Healthcare & Life Sciences BD at Amazon, where they led partnerships across multiple business units. Mark also served as the President and Chief Medical Officer at Butterfly Network, Inc. and Chief Medical Officer at Hyperfine Research, Inc. Their expertise ranges from data science and AI/ML to healthcare and life sciences, showcasing a strong background in the medical and technology fields.

Mark Michalski holds a B.S. in Cybernetics from UCLA. Mark then pursued a Doctor of Philosophy in Investigative Medicine from Yale University School of Medicine. Their education journey culminated in receiving an MD from Stanford University School of Medicine. Additionally, they hold certifications from the American Board of Radiology and the New York State Medical License.